Overview:
Buprenorphine is widely used in advanced healthcare for acute and chronic pain relief, as well as the treatment of opioid addiction. It’s a narcotic analgesic phenanthrene that’s been synthesized.
The global buprenorphine market is expected to be valued around US$ 3,681.9 million in 2020 and is expected to register a CAGR of 14.5% over the forecast period (2020-2027).
Request Here Sample with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/4237
Drivers:
Growing incidences of chronic pain is expected to drive growth of the global buprenorphine market over the forecast period.
Buprenorphine is an opioid that is used to treat acute and chronic pain in patients that are seeking treatment for multiple sclerosis, cancer, or other life-threatening illnesses. Furthermore, the high incidence of cancer is expected to pose demand for cancer therapies, which is expected to propel growth of global buprenorphine market. For instance, in 2018, according to Cancer Research UK, factsheet around 17 million people were diagnosed with cancer.
Moreover, rising prevalence of multiple sclerosis is expected to drive growth of the global buprenorphine market over the forecast period. For instance, in 2018, according to the Multiple Sclerosis Trust, an estimated 2,500,000 cases of multiple sclerosis are diagnosed globally.
Impact of Coronavirus (COVID-19) Pandemic
The coronavirus (COVID-19) epidemic and lockdowns in different countries around the world have had an effect on company’s financial status of all sectors. The private healthcare sector is one of the sector where the COVID-19 epidemic has had a huge effect. The healthcare system has been placed under financial pressure as a result of the epidemic’s lockdown in various countries.
Furthermore, the coronavirus epidemic has hindered the development, supply and manufacture of drugs and other health care products, as well as the growth of numerous healthcare businesses around the world. However, the global buprenorphine market is expected to slow growth due to the impact of COVID-19 epidemic over the forecast period.
Moreover, the COVID-19 infection, can cause pain in the joints and bones, which is expected to propel the global Buprenorphine market forward over the forecast period. For instance, in May 2020, according to the Journal of Clinical Orthopedics and Trauma, the coronavirus will damage the bones and joints of infected patients. As a result, numerous orthopedic doctors have been assigned to the task of monitoring coronavirus-infected patients. There has been an increase in the production of medicines as well as research and development of advanced solutions to treat such patients.
Get PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/4237
Key Takeaways of the Global Buprenorphine Market:
The global buprenorphine market is expected to register a CAGR around 14.5% over the forecast period due to growing incidence of abuse of heroin and drug, opioid addiction, chronic and acute pain control, osteoarthritis, and chronic pain associated with cancer treatment. For instance, in September 2017, according to the Hindawi Pain Research and Management Journal, an estimated 30 to 50% cases of chronic pain globally.
On the basis of application type, the opioid antagonist segment held a dominant position in the global buprenorphine market in 2019, due to its significance in the treatment of opioid addiction.
Among route of administration, the sublingual segment held a dominant position in the global buprenorphine market in 2019, due to the majority of newly released generics are in the form of sublingual films used to treat opioid addiction.
On the basis of distribution channel, hospital pharmacy segment held a dominant position in the global buprenorphine market in 2019, as the majority of cancer cases and osteoarthritis cases are reported at hospitals. Furthermore, the majority of important cancer treatments are carried out in hospitals.
Key players dominating in the global buprenorphine market such as Sanofi, Mallinckrodt, Johnson Matthey, Unichem Laboratories, Noramco, Faran Shimi Pharmaceutical Co., Resonance-labs, Arevipharma GmbH, Micro Orgo Chem, Rusan Pharma, Sun Pharmaceutical Industries Ltd. and Siegfried.
Reasons to Purchase this Report
• Current and future of global Buprenorphine market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Content
- Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Application
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Pipeline Analysis
- Reimbursement Scenario
- Epidemiology
- Pest Analysis
- Regulatory Scenario
- New Product Launches
- Collaborations and Agreements
- Market Trends
- Market Dynamics
- Global Buprenorphine Market – Impact of Coronavirus (COVID-19) Pandemic
- COVID-19 Market Scenario
- Impact of COVID-19 Market on the Buprenorphine Products
- Global Buprenorphine Market, By Application, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Analgesic
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Opioid Antagonist
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Buprenorphine Market, By Route of Administration, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Injectables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Sublingual
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Transdermal Patches
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Buprenorphine Market, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, 2017 – 2027
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
- Introduction
- Global Buprenorphine Market, By Region, 2016 – 2027, (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2020 and 2027 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2027
- North America
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- U.S.
- Canada
- Latin America
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- Germany
- U.K.
- France
- Italy
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
- Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
- South Africa
- Central Africa
- North Africa
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Siegfried
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sanofi
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Johnson Matthey
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Mallinckrodt
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Noramco
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Unichem Laboratories
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Arevipharma GmbH
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Resonance-labs
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Sun Pharmaceutical Industries Ltd.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Rusan Pharma
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Micro Orgo Chem
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Faran Shimi Pharmaceutical Co.
- Company Overview
- Product Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Siegfried
- Analyst Views
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837